StockData
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) stock

MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$398.08−23.91 (-5.67%)

Close on Nov 18, 2026Market cap $9.20BP/E –Yield –

Madrigal Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Madrigal Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $1.28B, up 149.0% year over year. For fiscal 2025 it was $958.40M, up 432.1% from the year before. The highest annual figure on record is $958.40M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$958.40M+432.1%
FY2024Dec 31, 2024$180.13M–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0–
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0-100.0%
FY2012Dec 31, 2012$147.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$364.25M+71.2%
Q1 FY2026Mar 31, 2026$311.34M+126.8%
Q4 FY2025Dec 31, 2025$321.08M+210.8%
Q3 FY2025Sep 30, 2025$287.27M+362.0%
Q2 FY2025Jun 30, 2025$212.80M+1353.8%
Q1 FY2025Mar 31, 2025$137.25M–
Q4 FY2024Dec 31, 2024$103.32M–
Q3 FY2024Sep 30, 2024$62.18M–
Q2 FY2024Jun 30, 2024$14.64M–
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–

More Madrigal Pharmaceuticals figures

See a number that looks wrong?